로딩 중…
StockDiggingStockDigging

Aligned Genetics, Inc.

238120· KOSDAQ
₩3,370-0.15%
2026-06-19

Price Chart

Aligned Genetics, Inc.+6.14%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap48.46B KRW
Revenue15.73B KRW
Net Income2.78B KRW
Total Assets58.96B KRW
Net Assets37.55B KRW
Employees66
Value
P/E17.46x
P/B1.29x
P/S3.08x
EV/EBITDA24.34x
FCF Yield-2.50%
Profitability
ROE7.39%
ROA4.71%
Op. Margin13.61%
Revenue Growth-7.16%
Earnings Growth-24.62%
Financial Health
Debt Ratio57.02%
Total Debt14.34B KRW
FCF-1.21B KRW
Cash10.67B KRW
Current Ratio4.95x
Net Debt/EBITDA1.71x
Performance
1Y Return6.14%
1M Return-9.16%
From 52W High-44.30%
1Y MDD-47.60%
Trading
Volume25,877 shares
Foreign Own.3.06%
Per Share
EPS193 KRW
BPS2,671 KRW

Company Info

CEO 정연철
Employees 66
Founded 2008
HQ 경기도 안양시, KR

Alligned, established in 2008 as a technology venture company developing, producing, and selling advanced equipment and reagents for life science research and diagnostics worldwide, was listed on the KOSDAQ market in 2016. It operates overseas sales corporations and branches in the United States, Europe, and Japan. Based on convergence technologies including bio, optics, electricity, electronics, and software, its main products are automatic cell counting systems, biological tissue clearing and imaging systems, and digital cell imaging systems.